Corrado Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,887
Closed -$1.58M 106
2024
Q4
$1.58M Sell
27,887
-4,838
-15% -$270K 1.03% 46
2024
Q3
$1.69M Sell
32,725
-411
-1% -$19.3K 1.06% 44
2024
Q2
$1.38M Sell
33,136
-1,305
-4% -$58.4K 0.89% 57
2024
Q1
$1.87M Sell
34,441
-891
-3% -$45.4K 1.23% 39
2023
Q4
$1.81M Sell
35,332
-1,316
-4% -$69.1K 1.48% 30
2023
Q3
$2.13M Buy
36,648
+710
+2% +$43.5K 1.47% 25
2023
Q2
$2.3M Sell
35,938
-185
-0.5% -$12.4K 1.61% 21
2023
Q1
$2.5M Buy
36,123
+1,036
+3% +$73.1K 1.66% 14
2022
Q4
$2.52M Buy
35,087
+561
+2% +$42.3K 1.77% 10
2022
Q3
$2.45M Sell
34,526
-445
-1% -$32.3K 1.99% 11
2022
Q2
$2.69M Buy
34,971
+53
+0.2% +$4.04K 1.91% 11
2022
Q1
$2.55M Buy
34,918
+680
+2% +$45.7K 1.56% 20
2021
Q4
$2.13M Buy
34,238
+629
+2% +$36.9K 1.28% 27
2021
Q3
$1.99M Buy
33,609
+298
+0.9% +$19.6K 1.23% 28
2021
Q2
$2.23M Buy
33,311
+2,970
+10% +$194K 1.37% 26
2021
Q1
$1.92M Sell
30,341
-740
-2% -$46K 1.42% 23
2020
Q4
$1.93M Sell
31,081
-2,269
-7% -$140K 1.48% 23
2020
Q3
$2.01M Sell
33,350
-412
-1% -$24.8K 1.67% 17
2020
Q2
$1.99M Sell
33,762
-7,280
-18% -$435K 1.8% 12
2020
Q1
$2.29M Sell
41,042
-13,835
-25% -$846K 2.14% 14
2019
Q4
$3.52M Sell
54,877
-3,890
-7% -$223K 3.13% 10
2019
Q3
$2.98M Sell
58,767
-755
-1% -$35.5K 2.68% 14
2019
Q2
$2.7M Buy
59,522
+28,726
+93% +$1.34M 2.41% 18
2019
Q1
$1.47M Buy
+30,796
New +$1.53M 1.35% 27

Other funds holding BMY

Corrado Advisors's BMY Position: Q1 2025 in Review

Corrado Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 27,887 shares — an estimated $1.58M sold.

Corrado Advisors first reported a position in BMY in Q1 2019 and held it in 24 quarters. The position peaked at $3.52M in Q4 2019. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Corrado Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Corrado Advisors sold 27,887 Bristol-Myers Squibb shares in Q1 2025, an estimated $1.58M.
  • Corrado Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 24 quarters.
  • Corrado Advisors's Bristol-Myers Squibb position peaked at $3.52M in Q4 2019.
  • 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Corrado Advisors's 13F filing for Q1 2025, filed 1 May 2025.